United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing

NewTimeSpace · 2026/07/14 19:24 · By Jiayi Sun

NewTimeSpace News: United Laboratories announced on 14 July that sodium hyaluronate eye drops (specification: 0.3%, 5ml:15mg) submitted by Zhongshan Branch of Zhuhai United Laboratories, its wholly-owned subsidiary, has passed the drug registration review and approval of the National Medical Products Administration and been granted marketing authorization.

NewTimeSpace News: On 14 July 2026, United Laboratories (03933.HK) issued an announcement that sodium hyaluronate eye drops (specification: 0.3% (5ml:15mg)) filed by Zhongshan Branch of Zhuhai United Laboratories Co., Ltd., the Company’s wholly-owned subsidiary, has been approved for marketing by the National Medical Products Administration (NMPA).

As disclosed in the announcement, this product is an artificial tear indicated for Sjögren’s syndrome, dry eye syndrome, and corneal and conjunctival epithelial injuries caused by surgery, medication, trauma and other factors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

United Laboratories 03933.HK